Raymond James Financial Services Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.09M | Sell |
3,638
-95
| -3% | -$28.5K | ﹤0.01% | 2100 |
|
|
2024
Q2 | $1.23M | Buy |
3,733
+42
| +1% | +$13.8K | ﹤0.01% | 1954 |
|
|
2024
Q1 | $1.46M | Buy |
3,691
+84
| +2% | +$33.2K | ﹤0.01% | 1834 |
|
|
2023
Q4 | $1.27M | Sell |
3,607
-428
| -11% | -$151K | ﹤0.01% | 1840 |
|
|
2023
Q3 | $1.51M | Buy |
4,035
+689
| +21% | +$259K | ﹤0.01% | 1662 |
|
|
2023
Q2 | $1.28M | Sell |
3,346
-20
| -0.6% | -$7.65K | ﹤0.01% | 1780 |
|
|
2023
Q1 | $1.17M | Buy |
3,366
+382
| +13% | +$132K | ﹤0.01% | 1809 |
|
|
2022
Q4 | $702K | Buy |
2,984
+967
| +48% | +$228K | ﹤0.01% | 2070 |
|
|
2022
Q3 | $496K | Sell |
2,017
-531
| -21% | -$131K | ﹤0.01% | 2252 |
|
|
2022
Q2 | $771K | Sell |
2,548
-2,458
| -49% | -$744K | ﹤0.01% | 2003 |
|
|
2022
Q1 | $2.06M | Buy |
5,006
+1,134
| +29% | +$466K | ﹤0.01% | 1469 |
|
|
2021
Q4 | $1.82M | Sell |
3,872
-2,533
| -40% | -$1.19M | ﹤0.01% | 1601 |
|
|
2021
Q3 | $2.72M | Buy |
6,405
+4,792
| +297% | +$2.03M | 0.01% | 1307 |
|
|
2021
Q2 | $579K | Sell |
1,613
-3,148
| -66% | -$1.13M | ﹤0.01% | 2278 |
|
|
2021
Q1 | $1.34M | Sell |
4,761
-493
| -9% | -$139K | ﹤0.01% | 1651 |
|
|
2020
Q4 | $1.49M | Buy |
5,254
+3,981
| +313% | +$1.13M | ﹤0.01% | 1469 |
|
|
2020
Q3 | $350K | Buy |
+1,273
| New | +$350K | ﹤0.01% | 2194 |
|